JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2005, 54(2):75-77

Preformulation Studies of Potential Drug XIX M: Partition Coefficient

Z. Capková1, Z. Vitková1, J. Tilandyová1, J. Čižmárik2
1 Farmaceutická fakulta Univerzity Komenského v Bratislave, Katedra galenickej farmácie
2 Farmaceutická fakulta Univerzity Komenského v Bratislave, Katedra farmaceutickej chémie

The factors which markedly influence availability of the drug from the dosage form include also auxiliary substances, which are an inevitable component in the formulation of the drug. In the selection of auxiliary substances for a newly formulated drug, it is necessary to know that the drug is never a simple mixture of mutually independent ingredients, but a dynamic system in which various physical and chemical processes take place. The present paper aims to study the effect of auxiliary substances from the group of humectants with graded concentrations and the effect of the preservative on the partition coefficient of potential drug XIX M. Partition coefficient (P') was estimated in the system n-octanol/aqueous solution with graded concentrations of polyols. In these estimations, n-octanol simulated the horny layer, and the aqueous solution the base of the topical preparation. The auxiliary substances employed were polyols - glycerol, propylene glycol, and sorbitol in 5, 10, 15, and 20% concentrations and an antimicrobially effective solution of Ajatin® (Solution benzododecinii bromati) in two concentrations of 0.01 and 0.1 wt %. It follows from the obtained results that the values of partition coefficient of potential drug XIX M are greatly influenced by auxiliary substances. The value of this parameter, and therefore also biological availability, depend not only on the sort of the polyol used and its concentration, but also on the concentration of the preservative employed, in this case Ajatin®.

Keywords: preformulation studies; partition coefficient; N-[2-(2-heptyloxyphenylcarbamoyloxy)-ethyl]-morpholinium chloride

Received: January 29, 2004; Accepted: March 5, 2004; Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Capková Z, Vitková Z, Tilandyová J, Čižmárik J. Preformulation Studies of Potential Drug XIX M: Partition Coefficient. Čes. slov. farm. 2005;54(2):75-77.
Download citation

References

  1. Čižmárik, J., Borovanský, A., Tumová, I.: Pharmazie, 1987; 42, 702-703. Go to original source... Go to PubMed...
  2. Gardavská, K., Vitková, Z., Čižmárik, J., Rak, J.: Čes. slov. Farm., 1998; 47, 124-127.
  3. De Jongh, J., Verhaar, H. J., Hermens, J. L.: Arch Toxicol., 1997; 72, 17-25. Go to original source... Go to PubMed...
  4. Ranade, V., Somberg, J. C.: Am. J. Ther., 2002; 9, 19-24. Go to original source... Go to PubMed...
  5. Jiang, X. G., Lu, X., Cui, J. B.: Yan Xue Xue Bao, 1997; 32, 458-460.
  6. Mertin, D., Lippold, B. C.: J. Pharm. Pharmacol, 1997; 49, 30-34. Go to original source... Go to PubMed...
  7. Slovenský liekopis, zväzok I. 1. vydanie, Bratislava, Herba, 1997, 74.
  8. Vitková, Z., Škarbalová, M., Klasovitá, J., Rak, J.: Čes. slov. Farm., 2002; 51, 22-40.
  9. Keil, B. et al.: Laboratorní technika biochemie. Praha, ČSA, 1959, 303.
  10. Vitková, Z., Gardavská, K., Čižmárik, J., Rak, J.: Acta Pol. Pharm. - Drug Res., 1998; 55, 25-27.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.